| Literature DB >> 34958046 |
Berzenn Urbi1,2, Joel Corbett3, Ian Hughes1, Maame Amma Owusu1, Sarah Thorning1, Simon A Broadley2,3, Arman Sabet2,3, Saman Heshmat2,4.
Abstract
The legalization of cannabis in many countries has allowed many Parkinson's disease (PD) patients to turn to cannabis as a treatment. As such there is a growing interest from the PD community to be properly guided by evidence regarding potential treatment benefits of cannabis. This systematic review and meta-analysis aims to compile the best available evidence to help guide patients and their family, clinicians and researchers make informed decisions. A systematic search of the literature was conducted in June 2021. Five randomized controlled studies and eighteen non-randomized studies investigated cannabis treatment in PD patients. No compelling evidence was found to recommend the use of cannabis in PD patients. However, a potential benefit was identified with respect to alleviation of PD related tremor, anxiety, pain, improvement of sleep quality and quality of life. Given the relative paucity of well-designed randomized studies, there is an identified need for further investigation, particularly in these areas.Entities:
Keywords: Cannabis; Parkinson’s disease; UPDRS; efficacy of cannabis; tremor
Mesh:
Substances:
Year: 2022 PMID: 34958046 DOI: 10.3233/JPD-212923
Source DB: PubMed Journal: J Parkinsons Dis ISSN: 1877-7171 Impact factor: 5.568